APPLICATIONS PUBLISHED 11 JUNE 2003

Published: 1-Dec-2003

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492

  • Pharmaceutical compsn having specific water activity
    Pharmacia & Upjohn 1317252*

  • Biological component comprising artificial membrane
    Emory University 1317245*

  • Sustained release particle dispersion
    Bodmeier, Roland 1317254*

  • Delivery capsules
    Biopress Technology International 1317255*

  • Pharmaceutical compsn having modified carrier
    Pharmacia & Upjohn 1317256*

  • Plaster cover for children
    Beiersdorf 1317257*

  • Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease
    Merck; University of Washington 1317258*

  • Prevention of acute sinusitis and sinus attack
    Warner-Lambert 1317259*

  • Methods for treating tumours using sulfonyl compounds
    Signature Bioscience 1317260*

  • Preparation for treating diseases of bone tissues
    Zakryote Aktsionernoe Obschevsto 1317261*

  • Use of rhein for preparing a medicine for preventing articular cartilage damage
    Negma-Lerads 1317263*

  • Combination of lipoic acids and conjugated acids for treating diabetic disorders
    BASF 1317264*

  • Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency
    Max-Delbrueck-Centrum fuer Molekulare Medizin 1317265*

  • Neuroprotective 2-pyrimidinamine compsns and related methods
    Ortho-McNeil Pharmaceutical 1317266*

  • Compsns containing diacyltartaric salts of (E)-metanicotine
    Targacept 1317267*

  • Targeted alpha particle therapy using actinium-225 conjugates
    Sloan Kettering Institute for Cancer Research 1317268*

  • Compsn containing a 15-keto prostaglandin compound for treating of ocular hypertension and glaucoma
    Sucampo 1317269*

  • Exemestane for the treatment of oestrogen-dependent cancers
    Pharmacia Italia 1317270*

  • Therapeutic and cosmetic uses of heparanases
    Insight Strategy & Marketing; Hadasit Medical Research Services & Development 1317271*

  • Compsn for improving the cell protection comprising a lipophilic antioxidant and a hydrophilic antioxidant
    Pharmaton 1317272*

  • Use of IL-6R/IL-6 chimera in Huntington's disease
    Ares Trading 1317273*

  • Peptide compsn for treatment of periodontal diseases and prevention of skin aging
    pepsyn 1317274*

  • Medicament comprising a DNA sequence which codes for the RNA-binding KOC protein, and comprising a KOC protein or a DNA sequence of the KOC promoter
    Mueller, Frederike 1317275*

  • Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects
    Baxter Healthcare 1317276*

  • Antifungal combination therapy
    Fujisawa Pharmaceuticals 1317277*

  • MUC1 extracellular domain and cancer treatment compsns and methods derived therefrom
    Kufe, Donald 1317278*

  • Vaccine against Streptococcus pneumoniae
    GlaxoSmithKline Biologicals 1317279*

  • Vaccine against Streptococcus pneumoniae
    GlaxoSmithKline 1317280*

  • Use of lipoproteins for immunotherapy of HIV-positive subjects
    Aventis Pasteur 1317281*

  • Vectors for molecule delivery to CD11B expressing cells
    Institut Pasteur 1317282*

  • Tweak receptor agonists and anti-angiogenic agents
    Biogen 1317283*

  • Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
    Micromet 1317284*

  • Methods for treating demyelinating diseases
    The Regents of the University of California 1317285*

  • Contraception process and administration form for the same
    Schering 1317286*

  • Polymeric conjugates of antitumour agents
    Pharmacia Italia 1317287*

  • Method and compsn for treating tumours by selective induction of apoptosis
    MUSC Foundation for Research Development 1317288*

  • You may also like